Skip to main content
Top
Published in: Diabetologia 6/2003

01-06-2003 | Article

The use of phage display to distinguish insulin autoantibody (IAA) from insulin antibody (IA) idiotypes

Authors: Dr. D. Devendra, T. S. Galloway, S. J. Horton, A. Evenden, U. Keller, T. J. Wilkin

Published in: Diabetologia | Issue 6/2003

Login to get access

Abstract

Aim/hypothesis

Radiobinding assays (RBA) are unable to differentiate insulin autoantibodies (IAA) from insulin antibodies (IA). We sought to establish whether random peptide phage display might generate reagents with which to distinguish IAA idiotopes from IA idiotopes.

Methods

Two insulin-binding sera were used to select phagotopes from a phage library. The first, designated IAS, came from an insulin-treated patient with the insulin autoimmune syndrome, and was known to contain both IA and a high titre of human insulin specific (B30 threonine dependent) IAA. The second, designated IDD, was taken from a newly-diagnosed IAA+ Type 1 diabetic patient. Phage colonies selected by insulin-purified IgG extracts of IAS and IDD were selected at random for DNA sequencing, and tested for their reactivity with insulin antibodies and ability to distinguish disease-associated idiotopes.

Results

Seven phagotopes bound IAS and the phagotope designated IAS-9, corresponding to sequence KRSRLDV, gave the highest binding standard deviation (SD) score. Seven phagotopes bound IDD and the phagotope designated IDD-10, corresponding to sequence LGRGGSK, bound most strongly. IAS-9 was able to displace insulin binding in IAS and all of ten insulin-treated Type 2 diabetic patients, but not the IAA present in any of the eight patients with newly-diagnosed Type 1 diabetes. IDD-10, on the other hand, could displace insulin binding detected in the sera of eight patients with untreated Type 1 diabetes (IAA), but not in IAS or sera of the insulin-treated Type 2 diabetics.

Conclusion

Phagotopes provide reagents which between them can distinguish positively as well as negatively diabetes-associated IAA from non-diabetes associated IAA and from IA.
Literature
1.
go back to reference Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1993) Diabetes Care 20:1183–1197 Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1993) Diabetes Care 20:1183–1197
2.
go back to reference Bonifacio E, Christie MR (1997) Islet cell antigens in the prediction and prevention of insulin-dependent diabetes mellitus. Ann Med 29:405–412PubMed Bonifacio E, Christie MR (1997) Islet cell antigens in the prediction and prevention of insulin-dependent diabetes mellitus. Ann Med 29:405–412PubMed
3.
go back to reference Palmer JP, Asplin CM, Clemons P et al. (1983) Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 222:1337–1339PubMed Palmer JP, Asplin CM, Clemons P et al. (1983) Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 222:1337–1339PubMed
4.
go back to reference Ziegler AG, Hummel M, Schenker M, Bonifacio E (1999) Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes 48:460–468PubMed Ziegler AG, Hummel M, Schenker M, Bonifacio E (1999) Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes 48:460–468PubMed
5.
go back to reference Wilkin TJ (1991) Autoantibodies as mechanisms, markers, and mediators of B-cell disease. Diabetes Metab Rev 7:105–120PubMed Wilkin TJ (1991) Autoantibodies as mechanisms, markers, and mediators of B-cell disease. Diabetes Metab Rev 7:105–120PubMed
6.
go back to reference Naserke HE, Dozio N, Ziegler AG, Bonifacio E (1998) Comparison of a novel micro-assay for insulin autoantibodies with the conventional radiobinding assay. Diabetologia 41:681–683CrossRefPubMed Naserke HE, Dozio N, Ziegler AG, Bonifacio E (1998) Comparison of a novel micro-assay for insulin autoantibodies with the conventional radiobinding assay. Diabetologia 41:681–683CrossRefPubMed
7.
go back to reference Yu L, Robles DT, Abiru N et al. (2000) Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. Proc Natl Acad Sci USA 97:1701–1706PubMed Yu L, Robles DT, Abiru N et al. (2000) Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. Proc Natl Acad Sci USA 97:1701–1706PubMed
8.
go back to reference Williams AJ, Bingley PJ, Bonifacio E, Palmer JP, Gale EA (1997) A novel micro-assay for insulin autoantibodies. J Autoimmun 10:473–478CrossRefPubMed Williams AJ, Bingley PJ, Bonifacio E, Palmer JP, Gale EA (1997) A novel micro-assay for insulin autoantibodies. J Autoimmun 10:473–478CrossRefPubMed
9.
go back to reference Diaz JL, Wilkin T (1987) Differences in epitope restriction of autoantibodies to native human insulin (IAA) and antibodies to heterologous insulin (IA). Diabetes 36:66–72PubMed Diaz JL, Wilkin T (1987) Differences in epitope restriction of autoantibodies to native human insulin (IAA) and antibodies to heterologous insulin (IA). Diabetes 36:66–72PubMed
10.
go back to reference Nell LJ, Hulbert C, Thomas JW (1989) Human insulin autoantibody fine specificity and H and L chain use. J Immunol 142:3063–3069PubMed Nell LJ, Hulbert C, Thomas JW (1989) Human insulin autoantibody fine specificity and H and L chain use. J Immunol 142:3063–3069PubMed
11.
go back to reference Schroer JA, Bender T, Feldmann RJ, Kim KJ (1983) Mapping epitopes on the insulin molecule using monoclonal antibodies. Eur J Immunol 13:693–700PubMed Schroer JA, Bender T, Feldmann RJ, Kim KJ (1983) Mapping epitopes on the insulin molecule using monoclonal antibodies. Eur J Immunol 13:693–700PubMed
12.
go back to reference Castano L, Ziegler AG, Ziegler R, Shoelson S, Eisenbarth GS (1993) Characterization of insulin autoantibodies in relatives of patients with type I diabetes. Diabetes 42:1202–1209PubMed Castano L, Ziegler AG, Ziegler R, Shoelson S, Eisenbarth GS (1993) Characterization of insulin autoantibodies in relatives of patients with type I diabetes. Diabetes 42:1202–1209PubMed
13.
go back to reference Thomas JW (2001) Antigen-specific responses in autoimmunity and tolerance. Immunol Res 23:235–244PubMed Thomas JW (2001) Antigen-specific responses in autoimmunity and tolerance. Immunol Res 23:235–244PubMed
14.
go back to reference Hirata Y, Nishimura H, Tominaga M, Ishizu H, Arimichi M (1972) Spontaneous hypoglycemia with insulin-autoimmunity. Nippon Naika Gakkai Zasshi 61:1296–1304PubMed Hirata Y, Nishimura H, Tominaga M, Ishizu H, Arimichi M (1972) Spontaneous hypoglycemia with insulin-autoimmunity. Nippon Naika Gakkai Zasshi 61:1296–1304PubMed
15.
go back to reference Sklenar I, Wilkin TJ, Diaz JL, Erb P, Keller U (1987) Spontaneous hypoglycemia associated with autoimmunity specific to human insulin. Diabetes Care 10:152–159PubMed Sklenar I, Wilkin TJ, Diaz JL, Erb P, Keller U (1987) Spontaneous hypoglycemia associated with autoimmunity specific to human insulin. Diabetes Care 10:152–159PubMed
16.
go back to reference Scott JK, Smith GP (1990) Searching for peptide ligands with an epitope library. Science 249:386–390PubMed Scott JK, Smith GP (1990) Searching for peptide ligands with an epitope library. Science 249:386–390PubMed
17.
go back to reference Osman AA, Uhlig H, Thamm B, Schneider-Mergener J, Mothes T (1998) Use of the phage display technique for detection of epitopes recognized by polyclonal rabbit gliadin antibodies. FEBS Lett 433:103–107CrossRefPubMed Osman AA, Uhlig H, Thamm B, Schneider-Mergener J, Mothes T (1998) Use of the phage display technique for detection of epitopes recognized by polyclonal rabbit gliadin antibodies. FEBS Lett 433:103–107CrossRefPubMed
18.
go back to reference Folgori A, Tafi R, Meola A et al. (1994) A general strategy to identify mimotopes of pathological antigens using only random peptide libraries and human sera. EMBO J 13 :2236–2243PubMed Folgori A, Tafi R, Meola A et al. (1994) A general strategy to identify mimotopes of pathological antigens using only random peptide libraries and human sera. EMBO J 13 :2236–2243PubMed
19.
go back to reference Geysen HM, Rodda SJ, Mason TJ (1986) The delineation of peptides able to mimic assembled epitopes. Ciba Found Symp 119:130–49PubMed Geysen HM, Rodda SJ, Mason TJ (1986) The delineation of peptides able to mimic assembled epitopes. Ciba Found Symp 119:130–49PubMed
20.
go back to reference Rowley MJ, Scealy M, Whisstock JC et al. 2000 Prediction of the immunodominant epitope of the pyruvate dehydrogenase complex E2 in primary biliary cirrhosis using phage display. J Immunol 164:3413–3419 Rowley MJ, Scealy M, Whisstock JC et al. 2000 Prediction of the immunodominant epitope of the pyruvate dehydrogenase complex E2 in primary biliary cirrhosis using phage display. J Immunol 164:3413–3419
21.
go back to reference Mennuni C, Santini C, Lazzaro D et al. 1997 Identification of a novel type 1 diabetes-specific epitope by screening phage libraries with sera from pre-diabetic patients. J Mol Biol 268:599–606 Mennuni C, Santini C, Lazzaro D et al. 1997 Identification of a novel type 1 diabetes-specific epitope by screening phage libraries with sera from pre-diabetic patients. J Mol Biol 268:599–606
22.
go back to reference Miao D, Yu L, Tiberti C et al. (2002) ICA512(IA-2) Epitope specific assays distinguish transient from diabetes associated autoantibodies. J Autoimmun 18:191–196CrossRefPubMed Miao D, Yu L, Tiberti C et al. (2002) ICA512(IA-2) Epitope specific assays distinguish transient from diabetes associated autoantibodies. J Autoimmun 18:191–196CrossRefPubMed
23.
go back to reference Uchigata Y, Tokunaga K, Nepom G et al. (1995) Differential immunogenetic determinants of polyclonal insulin autoimmune syndrome and monoclonal insulin autoimmune syndrome. Diabetes 44:1227–1232PubMed Uchigata Y, Tokunaga K, Nepom G et al. (1995) Differential immunogenetic determinants of polyclonal insulin autoimmune syndrome and monoclonal insulin autoimmune syndrome. Diabetes 44:1227–1232PubMed
24.
go back to reference Baker EN, Blundell TL, Cutfield JF et al. (1988) The structure of 2Zn pig insulin crystals at 1.5 A resolution. Philos Trans R Soc Lond B Biol Sci 319:369–456PubMed Baker EN, Blundell TL, Cutfield JF et al. (1988) The structure of 2Zn pig insulin crystals at 1.5 A resolution. Philos Trans R Soc Lond B Biol Sci 319:369–456PubMed
25.
go back to reference Kurapkat G, De Wolf E, Grotzinger J, Wollmer A (1997) Inactive conformation of an insulin despite its wild-type sequence. Protein Sci 6:580–587PubMed Kurapkat G, De Wolf E, Grotzinger J, Wollmer A (1997) Inactive conformation of an insulin despite its wild-type sequence. Protein Sci 6:580–587PubMed
26.
go back to reference Hua QX, Shoelson SE, Weiss MA (1992) Nonlocal structural perturbations in a mutant human insulin: sequential resonance assignment and 13C-isotope-aided 2D-NMR studies of [PheB24→Gly]insulin with implications for receptor recognition. Biochemistry 31:11940–11951PubMed Hua QX, Shoelson SE, Weiss MA (1992) Nonlocal structural perturbations in a mutant human insulin: sequential resonance assignment and 13C-isotope-aided 2D-NMR studies of [PheB24→Gly]insulin with implications for receptor recognition. Biochemistry 31:11940–11951PubMed
27.
go back to reference Casali P, Nakamura M, Ginsberg-Fellner F, Notkins AL (1990) Frequency of B cells committed to the production of antibodies to insulin in newly diagnosed patients with insulin-dependent diabetes mellitus and generation of high affinity human monoclonal IgG to insulin. J Immunol 144:3741–3747PubMed Casali P, Nakamura M, Ginsberg-Fellner F, Notkins AL (1990) Frequency of B cells committed to the production of antibodies to insulin in newly diagnosed patients with insulin-dependent diabetes mellitus and generation of high affinity human monoclonal IgG to insulin. J Immunol 144:3741–3747PubMed
28.
go back to reference Eguchi Y, Uchigata Y, Yao K et al. (1994) Longitudinal changes of serum insulin concentration and insulin antibody features in persistent insulin autoimmune syndrome (Hirata's disease). Autoimmunity 19:279–284PubMed Eguchi Y, Uchigata Y, Yao K et al. (1994) Longitudinal changes of serum insulin concentration and insulin antibody features in persistent insulin autoimmune syndrome (Hirata's disease). Autoimmunity 19:279–284PubMed
Metadata
Title
The use of phage display to distinguish insulin autoantibody (IAA) from insulin antibody (IA) idiotypes
Authors
Dr. D. Devendra
T. S. Galloway
S. J. Horton
A. Evenden
U. Keller
T. J. Wilkin
Publication date
01-06-2003
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 6/2003
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-003-1107-7

Other articles of this Issue 6/2003

Diabetologia 6/2003 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine